Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition

Pepper, C, Buggins, A G S, Jones, C H, Walsby, E J, Forconi, F, Pratt, G, Devereux, S, Stevenson, F K and Fegan, C (2014) Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition. Leukemia, 29. pp. 744-747. ISSN 0887-6924

[img] PDF - Published Version
Restricted to SRO admin only
Available under License Creative Commons Attribution.

Download (479kB)
Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Clinical and Experimental Medicine
Depositing User: Gemma Hamilton
Date Deposited: 02 Jan 2018 14:12
Last Modified: 02 Jan 2018 14:12
URI: http://sro.sussex.ac.uk/id/eprint/72557

View download statistics for this item

📧 Request an update